Geron (GERN)
(Delayed Data from NSDQ)
$3.95 USD
-0.13 (-3.19%)
Updated May 2, 2024 04:00 PM ET
After-Market: $3.96 +0.01 (0.25%) 7:58 PM ET
4-Sell of 5 4
F Value F Growth A Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: BMO |
3/2024 | $-0.10 | 0.00% |
Earnings Summary
For their last quarter, Geron (GERN) reported earnings of -$0.09 per share, beating the Zacks Consensus Estimate of $-0.10 per share. This reflects a positive earnings surprise of 10.00%. Look out for GERN's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year decrease of 42.86%.
Earnings History
Price & Consensus
Zacks News for GERN
Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More
GERN: What are Zacks experts saying now?
Zacks Private Portfolio Services